Home›Trial›NCT07010159
🔬NCT07010159Phase 2Phase 3RECRUITING

Phase 2/3 Study of KPL-387 in Recurrent Pericarditis

Study Summary

This study is being done to demonstrate whether KPL-387 is an effective and safe treatment for recurrent pericarditis.

Conditions
PericarditisPericarditis AcuteRecurrent Pericarditis
Interventions / Drugs
KPL-387Placebo
View on ClinicalTrials.gov ↗
Sponsor
KNSA
Kiniksa Pharmaceuticals
Rare Disease
D37/100
Study Details
Enrollment165 participants
Primary Completion—
Lead SponsorKiniksa Pharmaceuticals International, plc
Data Retrieved2026-04-11 04:18:52.793592+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.